Related Experiment Video
Updated: May 31, 2026
Retroviral Transduction of T-cell Receptors in Mouse T-cells
Published on: October 22, 2010
T-cell receptor gene therapy: critical parameters for clinical success
Carsten Linnemann1, Ton N M Schumacher, Gavin M Bendle
1Division of Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Abstract:
T-cell receptor (TCR) gene therapy aims to induce immune reactivity against tumors by introducing genes encoding a tumor-reactive TCR into patient T cells. This approach has been extensively tested in preclinical mouse models, and initial clinical trials have demonstrated the feasibility and potential of TCR gene therapy as a cancer treatment. However, data obtained from preclinical and clinical studies suggest that both the therapeutic efficacy and the safety of TCR gene therapy can be and needs to be further enhanced. This review highlights those strategies that can be followed to develop TCR gene therapy into a clinically relevant treatment option for cancer patients.
Insights
T-cell receptor (TCR) gene therapy shows promise for cancer treatment but requires enhanced efficacy and safety. This review explores strategies to optimize TCR gene therapy for clinical relevance.
Area of Science:
- Immunotherapy
- Oncology
- Gene Therapy
Background:
- T-cell receptor (TCR) gene therapy introduces tumor-reactive TCR genes into patient T cells to fight cancer.
- Preclinical and early clinical studies confirm the feasibility and potential of this approach.
- Current limitations necessitate improvements in both therapeutic efficacy and safety.
Purpose of the Study:
- To review strategies for enhancing TCR gene therapy.
- To guide the development of TCR gene therapy into a clinically viable cancer treatment.
Main Methods:
- Literature review of preclinical and clinical studies on TCR gene therapy.
- Analysis of data on therapeutic efficacy and safety.
- Identification of key strategies for optimization.
Main Results:
- TCR gene therapy has demonstrated potential but requires further enhancement.
- Various strategies exist to improve efficacy and safety.
- Optimization is crucial for clinical translation.
Conclusions:
- Further development of TCR gene therapy is essential for its clinical application.
- Implementing enhancement strategies can improve patient outcomes.
- TCR gene therapy holds significant promise as a future cancer treatment.
